Diabetes care is preventive care: End-organ protection in patients with diabetes

Dr Hertzel Gerstein is a professor of medicine at the Faculty of Health Sciences at McMaster University and fellow of the Canadian Academy of Health Sciences.

See also

McMaster International Review Course in Internal Medicine (MIRCIM) Join us at the 7th edition of MIRCIM. Our readers can enjoy a great discount: 40% off the regular participation fee!
Management of atrial fibrillation according to the latest practice guidelines: Which strategy to choose and what are the consequences A lecture by Dr Tatjana Potpara from University of Belgrade, Serbia, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
Aortic aneurysm: when to call a vascular surgeon and what to expect from invasive treatment A lecture by Dr Stephan Haulon from Surgical Centre Marie Lannelongue, Le Plessis Robinson, France, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
COVID-19 and the cardiovascular system A lecture by Dr Reinhold Kreutz from Charité – Medical University Berlin, Germany, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
Acute pulmonary embolism: how to diagnose quickly and treat effectively A lecture by Dr Adam Torbicki from Center of Postgraduate Medical Education, Poland, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
What's new in the management of chronic heart failure A lecture by Dr Harriette Van Spall from McMaster University, Canada, delivered at the McMaster International Review Course in Internal Medicine (MIRCIM) in 2021.
The 3 most important recent advances in the management of nonmalignant blood diseases Dr Mark Crowther from McMaster University shares his views on the 3 most important recent advances in the management of nonmalignant blood diseases.
The 3 most important recent advances in treating respiratory failure Dr Bram Rochwerg from McMaster University shares his views on the 3 most important recent advances in treating respiratory failure.
CKD and obesity How big a problem is the coexistence of chronic kidney disease (CKD) and obesity? In a person starting renal replacement therapy, is obesity or malnutrition a greater risk?
Concentrated long-acting insulin analogues in type 2 diabetes What is the place of long-acting insulin analogues with higher than standard concentrations (200 IU/mL and 300 IU/mL) in the treatment of type 2 diabetes? In which patients should we expect the benefits to justify recommending the drug despite the higher cost to the patient?

Diabetes care is preventive care: End-organ protection in patients with diabetes

Social Media